Multimodal digital assessment of depression with actigraphy and app in Hong Kong Chinese.
Jie ChenNgan Yin ChanChun-Tung LiJoey Wing Yan ChanYaping LiuShirley Xin LiSteven Wai-Ho ChauKwong-Sak LeungPheng-Ann HengTatia Mei-Chun LeeTim M H LiYun-Kwok WingPublished in: Translational psychiatry (2024)
There is an emerging potential for digital assessment of depression. In this study, Chinese patients with major depressive disorder (MDD) and controls underwent a week of multimodal measurement including actigraphy and app-based measures (D-MOMO) to record rest-activity, facial expression, voice, and mood states. Seven machine-learning models (Random Forest [RF], Logistic regression [LR], Support vector machine [SVM], K-Nearest Neighbors [KNN], Decision tree [DT], Naive Bayes [NB], and Artificial Neural Networks [ANN]) with leave-one-out cross-validation were applied to detect lifetime diagnosis of MDD and non-remission status. Eighty MDD subjects and 76 age- and sex-matched controls completed the actigraphy, while 61 MDD subjects and 47 controls completed the app-based assessment. MDD subjects had lower mobile time (P = 0.006), later sleep midpoint (P = 0.047) and Acrophase (P = 0.024) than controls. For app measurement, MDD subjects had more frequent brow lowering (P = 0.023), less lip corner pulling (P = 0.007), higher pause variability (P = 0.046), more frequent self-reference (P = 0.024) and negative emotion words (P = 0.002), lower articulation rate (P < 0.001) and happiness level (P < 0.001) than controls. With the fusion of all digital modalities, the predictive performance (F1-score) of ANN for a lifetime diagnosis of MDD was 0.81 and 0.70 for non-remission status when combined with the HADS-D item score, respectively. Multimodal digital measurement is a feasible diagnostic tool for depression in Chinese. A combination of multimodal measurement and machine-learning approach has enhanced the performance of digital markers in phenotyping and diagnosis of MDD.
Keyphrases
- major depressive disorder
- bipolar disorder
- neural network
- machine learning
- depressive symptoms
- sleep quality
- pain management
- poor prognosis
- autism spectrum disorder
- climate change
- clinical trial
- artificial intelligence
- disease activity
- physical activity
- rheumatoid arthritis
- risk assessment
- chronic pain
- human health
- placebo controlled